` Comparison: 2R3 vs LLY - Alpha Spread

R
2R3
vs
LLY

Over the past 12 months, 2R3 has underperformed LLY, delivering a return of 0% compared to the LLY's +12% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
2R3
LLY
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

R
2R3 Intrinsic Value
Not Available
LLY Intrinsic Value
613.44 USD
Overvaluation 41%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
R
Reata Pharmaceuticals Inc
F:2R3
161 EUR
Eli Lilly and Co
NYSE:LLY
1 044.51 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
2R3, LLY

2R3
LLY
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
R
Reata Pharmaceuticals Inc
Revenue
Eli Lilly and Co
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
2R3, LLY

2R3
LLY
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
R
Reata Pharmaceuticals Inc
F:2R3
Eli Lilly and Co
NYSE:LLY
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

2R3
93.3%
LLY
83%

Operating Margin

2R3
-1 455.1%
LLY
45.6%

Net Margin

2R3
-373.2%
LLY
31.7%

FCF Margin

2R3
-1 062.4%
LLY
9.2%

ROE

2R3
-112.4%
LLY
101.4%

ROA

2R3
-15.5%
LLY
21.6%

ROIC

2R3
-231.6%
LLY
27.7%

ROCE

2R3
-71%
LLY
46.6%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
2R3, LLY

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
2R3, LLY

Loading
2R3
LLY
Difference
www.alphaspread.com

Performance By Year
2R3, LLY

Loading
2R3
LLY
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 2R3 to other stocks
JNJ
Johnson & Johnson
Cheaper
vs 2R3
ROG
Roche Holding AG
Cheaper
vs 2R3
NOVN
Novartis AG
Cheaper
vs 2R3
AZN
AstraZeneca PLC
Cheaper
vs 2R3
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett